ClinicalTrials.gov
public full text
Public Domain
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
This study will assess the efficacy and safety of Mircera given intravenously in the treatment of renal anemia in chronic kidney disease patients on dialysis who are not currently receiving epoetin or any other erythropoietic substance. The anticipated time on study treatment is 1-2 years and the target sample size is 100-500 individuals.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.#1089135
- A Study of Mircera in Renal Anemia Among Filipino Chronic Kidney Disease Patients#913271
- A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients#829513
- A Study of Mircera (C.E.R.A.) in Patients With Pre-Dialysis Chronic Renal Anemia#1137252
- A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.#1153043
Record · ID 840802
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive